Search results
Results from the WOW.Com Content Network
Ribociclib, sold under the brand name Kisqali, is a medication used for the treatment of certain kinds of breast cancer. [4] Ribociclib is a kinase inhibitor. [ 4 ] It was developed by Novartis and Astex Pharmaceuticals .
It may also cause fewer side effects, Teplinksy said. The expanded approval is for patients with HR-positive, HER2-negative breast cancer, the most common form of the disease .
Kwashiorkor is a type of severe acute malnutrition (SAM). SAM is a category, composed of two conditions: marasmus and kwashiorkor. [9] Both kwashiorkor and marasmus fall under the umbrella of protein–energy malnutrition (PEM). [10]
“Bloating is generally best handled by finding the cause and avoiding it,” Dr. Kim says. If you aren’t sure what’s causing your bloating, this is when working with a G.I. doc can be helpful.
One of the causes of abnormal bloating is excessive eating and air swallowing, known as aerophagia. [2] Other causes of bloating and distension include inflammatory bowel diseases such as Crohn's disease [ 3 ] [ 4 ] and ulcerative colitis , irritable bowel syndrome , diabetes , functional dyspepsia , or transient constipation .
Weight-loss medications and teens At the start of 2023, the American Academy of Pediatrics (AAP) released its first new guidelines in 15 years on evaluating and treating childhood obesity.
Body weight is reduced to less than 62% of the normal (expected) body weight for the age. [1] Marasmus occurrence increases before age 1, whereas kwashiorkor occurrence increases after 18 months. It can be distinguished from kwashiorkor in that kwashiorkor is protein deficiency with adequate energy intake whereas marasmus has inadequate energy ...
For premium support please call: 800-290-4726 more ways to reach us